A small Chinese study showed that among those hospitalized with COVID-19, the percentage of those who wore eyeglasses for more than 8 hours per day was less (5.8%) than the rate of myopia in the general population (31.5%). The authors…

The American Dental Association (ADA) has expressed its support of House Bill Small Business PPE Tax Credit Act (HR 7216), which provides a tax credit for small businesses to offset the expense of purchasing personal protective equipment…

Dentists can take advantage of the research and development tax credit (R&D) that other industries have benefitted from for years. These R&D tax credits can amount to dollar-for-dollar savings on federal (and possibly state) income…

The University of Michigan (U-M) School of Dentistry welcomes three new full-time faculty members who specialize in cariology, restorative sciences and oral and maxillofacial surgery. 

A University of Bristol study assessed how much xylitol is released in medicated chewing gum by using a robot to replicate human chewing motion. This development may provide opportunities to refine drug release from gum via this delivery…

Two University of California, San Francisco (UCSF) projects have received funding from the National Institute of Dental and Craniofacial Research to continue studies of hydrogel therapies. The teams hope the projects will lead to…

A Phase 3 clinical trial on a COVID-19 vaccine being developed by AstraZeneca in partnership with Oxford University was put on hold after a participant in the United Kingdom (UK)-based study developed severe spinal cord inflammation. The…

Patients are returning to the dental office, with 99% of practices open and patient volumes hovering at nearly 75% of pre-pandemic rates, according to the American Dental Association Health Policy Institute. This healthy recovery may be…

The Organization for Safety, Asepsis and Prevention (OSAP), a community of clinicians, educators, consultants, researchers, industry representatives, and compliance directors who advocate for safe and infection-free delivery of oral…

Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have found that tipifarnib showed promise in treating HNSCC tumors with mutations in the HRAS gene.